Zobrazeno 1 - 10
of 19
pro vyhledávání: '"F P, Ognibene"'
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 151:795-799
Autor:
James H. Shelhamer, Pierre Larivée, Carolea Logun, C. W. Angus, F P Ognibene, Stewart J. Levine
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 12:196-204
Tumor necrosis factor-alpha (TNF-alpha) is a multifunctional, proinflammatory cytokine that is capable of activating a diverse number of target genes within multiple cell types. Little information is known regarding the role of TNF-alpha in the regul
Autor:
R O, Cannon, A N, Schechter, J A, Panza, F P, Ognibene, M E, Pease-Fye, M A, Waclawiw, J H, Shelhamer, M T, Gladwin
Publikováno v:
The Journal of clinical investigation. 108(2)
Nitric oxide (NO) may be stabilized by binding to hemoglobin, by nitrosating thiol-containing plasma molecules, or by conversion to nitrite, all reactions potentially preserving its bioactivity in blood. Here we examined the contribution of blood-tra
Publikováno v:
Journal of critical care. 13(4)
Bolus thermodilution cardiac output (BCO) measurements are affected by variations in injectate volume, rate, and temperature. These variations are eliminated when CO is measured by a continuous automated thermal technique (CCO). Further, CCO eliminat
Autor:
F P, Ognibene
Publikováno v:
Advances in internal medicine. 42
Autor:
D L, Medin, F P, Ognibene
Publikováno v:
Respiratory care. 40(8)
Publikováno v:
Critical care medicine. 22(12)
To evaluate left ventricular performance in patients with septic shock, using a load-independent measure of left ventricular systolic function, the peak systolic pressure/end-systolic volume index ratio.National Institutes of Health research facility
Autor:
J S, Fisherman, M, McCabe, M, Noone, F P, Ognibene, B, Goldspiel, D J, Venzon, K H, Cowan, J A, O'Shaughnessy
Publikováno v:
Journal of the National Cancer Institute. Monographs. (15)
The objective of this phase I trial was to determine the maximal tolerated dose (MTD) of Taxol and doxorubicin administered as a simultaneous intravenous infusion over 72 hours every 21 days. Granulocyte-colony stimulating factor (G-CSF) 10 microgram
Publikováno v:
The Pediatric infectious disease journal. 11(4)
Aerosolized pentamidine has been recommended as an alternative mode of antipneumocystis prophylaxis in human immunodeficiency virus-infected children with trimethoprim-sulfamethoxazole intolerance. However, there have been no definitive data concerni
Publikováno v:
Oncology nursing forum. 19(3)
A parent education booklet describing Pneumocystis carinii pneumonia (PCP) was prepared by the Pediatric Branch of the National Cancer Institute. In addition to information about prophylaxis and treatment of PCP, the booklet discusses overall care of